Showing results (51-60 of 289) with videos related to
Sort By:
Pageof 29
Peptides|January 13, 2006
Pituitary adenylate cyclase-activating peptide (PACAP): assessment of dipeptidyl peptidase IV degradation, insulin-releasing activity and antidiabetic potentialB D Green, N Irwin, P R FlattInternational Journal of Obesity|January 1, 1982
Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob miceC J Bailey, P R Flatt, T W AtkinsThe Journal of Nutrition|September 1, 1991
Somatostatin, gastrin-releasing peptide and gastrin in the stomach of rats with streptozotocin-induced diabetes and insulinomaP R Flatt, C J Bailey, J M ConlonBritish Journal of Pharmacology|March 21, 1998
Insulin-releasing action of the novel antidiabetic agent BTS 67 582N H McClenaghan, P R Flatt, C J BaileyBritish Journal of Pharmacology|May 12, 2000
Induced desensitization of the insulinotropic effects of antidiabetic drugs, BTS 67 582 and tolbutamideN H McClenaghan, A J Ball, P R FlattThe Journal of Endocrinology|September 1, 1989
Effect of ovarian hormones, pregnancy and lactation on somatostatin and substance P in the alimentary tract of miceC J Bailey, J M Conlon, P R FlattRegulatory Peptides|December 15, 2010
Alterations of glucose-dependent insulinotropic polypeptide (GIP) during cold acclimationN Irwin, J M E Francis, P R FlattBiochemical Pharmacology|March 10, 2001
Specific desensitization of sulfonylurea- but not imidazoline-induced insulin release after prolonged tolbutamide exposureN H McClenaghan, A J Ball, P R FlattBiochemical and Biophysical Research Communications|August 26, 1998
Na+ cotransport by metabolizable and nonmetabolizable amino acids stimulates a glucose-regulated insulin-secretory responseN H McClenaghan, C R Barnett, P R FlattBioscience Reports|September 1, 1985
Islet cell surface antibodies in genetically obese hyperglycaemic (ob/ob) miceP R Flatt, A J Bone, C J BaileyPageof 29